{"id":391413,"date":"2020-12-02T05:29:05","date_gmt":"2020-12-02T10:29:05","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=391413"},"modified":"2020-12-02T05:29:05","modified_gmt":"2020-12-02T10:29:05","slug":"regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/","title":{"rendered":"Regent Pacific&#8217;s Strategic Partner Receives Approval from NMPA to Submit IND Application"},"content":{"rendered":"<div class=\"xn-newslines\">\n<h2 class=\"xn-hedline\">Important Milestone for SENSTEND\u2122, Solution to Premature Ejaculation to Market in China<\/h2>\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">HONG KONG<\/span>, <span class=\"xn-chron\">Dec. 2, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0<b>Regent Pacific Group Limited (&#8220;Regent Pacific&#8221; or the &#8220;Company&#8221; and together with its subsidiaries, the &#8220;Group&#8221;;<\/b> stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Wanbang Pharmaceutical Marketing and Distribution Co., Ltd. (&#8220;Wanbang Pharmaceutical&#8221;), a wholly controlled company of Shanghai Fosun Pharma, Regent Pacific&#8217;s commercial strategic partner in <span class=\"xn-location\">China<\/span>, has received approval from the National Medical Products Administration (&#8220;NMPA&#8221;) to submit the investigational new drug (&#8220;IND&#8221;) application for human clinical trial of a Licensed Product at NMPA.<\/p>\n<p>Under the terms of the licence agreement with Wanbang Pharmaceutical, Regent Pacific is now entitled to receive a payment of <span class=\"xn-money\">US$800,000<\/span> (approximately <span class=\"xn-money\">HK$6.24 million<\/span>) from Wanbang Pharmaceutical which is payable within 30 business days. NMPA will now formally review for Clinical Trial Approval (&#8220;CTA&#8221;). It is expected that the CTA will be obtained from the Center of Drug <span id=\"spanHghltdb07\">Evaluation by<\/span> the end of Q1 2021.\u00a0Another payment of <span class=\"xn-money\">US$3.20 million<\/span> (approximately <span class=\"xn-money\">HK$24.96 million<\/span>) will be received upon the successful approval from NMPA to commence the clinical trial.<\/p>\n<p>\n        <b><br \/>\n          <span class=\"xn-person\">Jamie Gibson<\/span>, Chief Executive Officer of Regent Pacific<\/b>, said, &#8220;This is an important milestone in achieving approval to market Senstend\u2122 in <span class=\"xn-location\">China<\/span>. We will continue to work closely and diligently with our current and prospective commercial partners and will keep shareholders and potential investors informed of any new developments as and when they occur.&#8221;<\/p>\n<p>\n        <b>About Regent Pacific<\/b>\n      <\/p>\n<p>Regent Pacific is a diversified investment group based in <span class=\"xn-location\">Hong Kong<\/span> currently holding various corporate and strategic investments focusing on the healthcare, wellness and life sciences sectors. The Group has a strong track record of investments and has returned approximately <span class=\"xn-money\">US$298 million<\/span> to shareholders in the 23 years of financial reporting since its initial public offering in May 1997.\u00a0<\/p>\n<p>\n        <b>About Fortacin\u2122 \/ Sendstend\u2122<\/b>\n      <\/p>\n<p>Fortacin\u2122 \/ Sendstend\u2122 is the first solution to premature ejaculation (PE) that does not act on the central nervous system and offers bona fide therapeutic efficacy that has been validated through extensive clinical trials in <span class=\"xn-location\">Europe<\/span>, with over 23,500 doses delivered to trial participants. The solution is a topical spray containing low doses of lidocaine and prilocaine that take effect almost immediately upon application, giving users more control without reducing pleasure. Fully approved by the European Medicines Agency (EMA), Fortacin\u2122 is now available in <span class=\"xn-location\">France<\/span>, <span class=\"xn-location\">Germany<\/span>, <span class=\"xn-location\">Italy<\/span>, <span class=\"xn-location\">Portugal<\/span>, <span class=\"xn-location\">Spain<\/span> and the <span id=\"spanHghltfc35\">UK.<\/span><\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN09443&amp;sd=2020-12-02\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application-301183458.html\">http:\/\/www.prnewswire.com\/news-releases\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application-301183458.html<\/a><\/p>\n<p>SOURCE  Regent Pacific Group Limited<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CN09443&amp;Transmission_Id=202012020525PR_NEWS_USPR_____CN09443&amp;DateId=20201202\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Important Milestone for SENSTEND\u2122, Solution to Premature Ejaculation to Market in China PR Newswire HONG KONG, Dec. 2, 2020 \/PRNewswire\/ &#8212;\u00a0Regent Pacific Group Limited (&#8220;Regent Pacific&#8221; or the &#8220;Company&#8221; and together with its subsidiaries, the &#8220;Group&#8221;; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Wanbang Pharmaceutical Marketing and Distribution Co., Ltd. (&#8220;Wanbang Pharmaceutical&#8221;), a wholly controlled company of Shanghai Fosun Pharma, Regent Pacific&#8217;s commercial strategic partner in China, has received approval from the National Medical Products Administration (&#8220;NMPA&#8221;) to submit the investigational new drug (&#8220;IND&#8221;) application for human clinical trial of a Licensed Product at NMPA. Under the terms of the licence agreement with Wanbang Pharmaceutical, Regent Pacific is now entitled &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Regent Pacific&#8217;s Strategic Partner Receives Approval from NMPA to Submit IND Application&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-391413","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regent Pacific&#039;s Strategic Partner Receives Approval from NMPA to Submit IND Application - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regent Pacific&#039;s Strategic Partner Receives Approval from NMPA to Submit IND Application - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Important Milestone for SENSTEND\u2122, Solution to Premature Ejaculation to Market in China PR Newswire HONG KONG, Dec. 2, 2020 \/PRNewswire\/ &#8212;\u00a0Regent Pacific Group Limited (&#8220;Regent Pacific&#8221; or the &#8220;Company&#8221; and together with its subsidiaries, the &#8220;Group&#8221;; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Wanbang Pharmaceutical Marketing and Distribution Co., Ltd. (&#8220;Wanbang Pharmaceutical&#8221;), a wholly controlled company of Shanghai Fosun Pharma, Regent Pacific&#8217;s commercial strategic partner in China, has received approval from the National Medical Products Administration (&#8220;NMPA&#8221;) to submit the investigational new drug (&#8220;IND&#8221;) application for human clinical trial of a Licensed Product at NMPA. Under the terms of the licence agreement with Wanbang Pharmaceutical, Regent Pacific is now entitled &hellip; Continue reading &quot;Regent Pacific&#8217;s Strategic Partner Receives Approval from NMPA to Submit IND Application&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-02T10:29:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN09443&amp;sd=2020-12-02\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Regent Pacific&#8217;s Strategic Partner Receives Approval from NMPA to Submit IND Application\",\"datePublished\":\"2020-12-02T10:29:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/\"},\"wordCount\":425,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN09443&amp;sd=2020-12-02\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/\",\"name\":\"Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN09443&amp;sd=2020-12-02\",\"datePublished\":\"2020-12-02T10:29:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN09443&amp;sd=2020-12-02\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN09443&amp;sd=2020-12-02\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regent Pacific&#8217;s Strategic Partner Receives Approval from NMPA to Submit IND Application\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/","og_locale":"en_US","og_type":"article","og_title":"Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application - Market Newsdesk","og_description":"Important Milestone for SENSTEND\u2122, Solution to Premature Ejaculation to Market in China PR Newswire HONG KONG, Dec. 2, 2020 \/PRNewswire\/ &#8212;\u00a0Regent Pacific Group Limited (&#8220;Regent Pacific&#8221; or the &#8220;Company&#8221; and together with its subsidiaries, the &#8220;Group&#8221;; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Wanbang Pharmaceutical Marketing and Distribution Co., Ltd. (&#8220;Wanbang Pharmaceutical&#8221;), a wholly controlled company of Shanghai Fosun Pharma, Regent Pacific&#8217;s commercial strategic partner in China, has received approval from the National Medical Products Administration (&#8220;NMPA&#8221;) to submit the investigational new drug (&#8220;IND&#8221;) application for human clinical trial of a Licensed Product at NMPA. Under the terms of the licence agreement with Wanbang Pharmaceutical, Regent Pacific is now entitled &hellip; Continue reading \"Regent Pacific&#8217;s Strategic Partner Receives Approval from NMPA to Submit IND Application\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-02T10:29:05+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN09443&amp;sd=2020-12-02","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Regent Pacific&#8217;s Strategic Partner Receives Approval from NMPA to Submit IND Application","datePublished":"2020-12-02T10:29:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/"},"wordCount":425,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN09443&amp;sd=2020-12-02","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/","name":"Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN09443&amp;sd=2020-12-02","datePublished":"2020-12-02T10:29:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN09443&amp;sd=2020-12-02","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN09443&amp;sd=2020-12-02"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regent-pacifics-strategic-partner-receives-approval-from-nmpa-to-submit-ind-application\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Regent Pacific&#8217;s Strategic Partner Receives Approval from NMPA to Submit IND Application"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/391413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=391413"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/391413\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=391413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=391413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=391413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}